IsoPlexis Corp
Funding rounds
6 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2020 | $85 M | No. 6 | $50 to $250 million | equity, options | SEC | |
| Nov 2018 | $20 M | No. 5 | $10 to $50 million | equity, options | SEC | |
| Jul 2017 | $5 M | No. 4 | $2 to $10 million | equity, options | SEC | |
| Jun 2016 | $6 M | No. 3 | $2 to $10 million | equity, options | SEC | |
| May 2015 | $2 M | No. 2 | $2 to $10 million | equity | SEC | |
| Jul 2014 | $1 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
IsoPlexis Corp chose not to state its revenue in its newest notice of a funding round (Jan 2021).
SEC Form D · Jan 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jan 2021
That is all the official record says: IsoPlexis Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
16 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Northpond Capital GP, LLC | Fund or asset manager | not stated | not stated | Held Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Northpond Capital, L.P. | Fund or asset manager | not stated | not stated | Held Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Northpond Ventures GP, LLC | Venture capital | not stated | not stated | Held Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Northpond Ventures, LP | Venture capital | not stated | not stated | Held Series C, C-2 and D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Pcof Eq Aiv III, LP | Fund or asset manager | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Perceptive Advisors LLC | Fund or asset manager | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Perceptive Credit Advisors, LLC | Fund or asset manager | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Perceptive Credit Holdings III, LP | Fund or asset manager | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Perceptive Life Sciences Master Fund LTD | Fund or asset manager | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SMC Growth Capital II GP, LLC | Fund or asset manager | not stated | not stated | Held Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SMC Growth Capital Partners II, LP | Fund or asset manager | not stated | not stated | Held Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SMC Holdings II G.P., LLC | Other | not stated | not stated | Held Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SMC Holdings II, LP | Fund or asset manager | not stated | not stated | Held Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SMC Private Equity Holdings GP, LLC | Private equity | not stated | not stated | Held Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SMC Private Equity Holdings, LP | Private equity | not stated | not stated | Held Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Spring Mountain Capital G.P., LLC | Fund or asset manager | not stated | not stated | Held Series A, A-2, B, B-2, C and C-2 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 10 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| John Strahley | Executive officer | Jan 2021 |
| Sean Mackay | Executive officer | Jan 2021 |
| Sean McKay | Executive officer | Jun 2016 |
| Daniel Wagner | Director | Jan 2021 |
| Gregory Ho | Director | Jan 2021 |
| James Heath | Director | Jan 2021 |
| John Conley | Director | Jan 2021 |
| Michael Egholm | Director | Jan 2021 |
| Sean Mackay | Director | Jan 2021 |
| Sharon Kedar | Director | Jan 2021 |
| Rong Fan | Director | Jun 2016 |
| Sean McKay | Director | Jun 2016 |